| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |